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Abstract 
Presently, there is limited knowledge regarding the differentiation of osteoclasts in the 
presence of nanoscale bioactive glasses (nBG). This investigation examined increasing 
concentrations of 45S5 nBG and its influence on osteoclast differentiation. After 14 days of 
culturing cells with 500 µg/ml nBG viability of ~100% was detected, however DNA synthesis 
was reduced supporting the differentiation into osteoclast-like cells. RNA activation of nine 
genes occurred in a nBG concentration dependent manner. Low concentrations of nBG 
increased expression of genes involved in commitment to cell fusion. High concentration of 
nBG increased gene expression supporting osteoclast-like differentiation. We conclude that 
nBG enhances RAW 264.7 osteoclast differentiation especially controlling gene expression 
in a concentration dependent manner, which could reflect normal regulation during bone 
growth.  
 
 
Background: There is limited knowledge regarding differentiation of osteoclasts in the 
presence of nanoscale bioactive glasses (nBG). This investigation examined increasing 
concentrations of 45S5 nBG and its influence on osteoclast differentiation.  
Materials and Methods: Different concentrations of 45S5 nBG were cultured up to 14 days 
with the murine RAW264.7 cell line and human primary monocytes and M-CSF and RANKL. 
Results: Culturing cells for 14 days with 500 µg/ml nBG showed a viability of 100%; however 
DNA synthesis was reduced, supporting differentiation into osteoclast-like cells. Using RAW 
cells, activation of nine genes, including cell fusion genes, occurred in an nBG concentration 
dependent manner. Low concentrations of nBG increased expression of genes involved in 
commitment to cell fusion, whereas high concentrations increased gene expression 
supporting osteoclast-like differentiation.  
Conclusion: nBG enhances both RAW264.7 and human osteoclast differentiation. nBG 
controlled gene expression in a concentration dependent manner could reflect normal 
regulation during bone growth.  
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1. Introduction 
World-wide there are more than 2 million cases per year involving patients needing bone-
grafts for dental or orthopaedic procedures due to bone injuries and disease complications 
like tumor destruction of bone [1]. In light of the fact that bone has a healing capacity through 
bone remodeling in response to injury or tumor destruction, the limiting factor for 
regeneration is linked not only with the individual’s age but also with the amount of bone loss 
or damage. Despite the possibility of using auto-, allo- or xenografts for bone replacement 
there are clinical risks including graft availability, infection, reduced mechanical movement, a 
poorly functioning graft or graft rejection [2]. Bone tissue engineering represents an 
alternative to current approaches with ultimate goal being the combination of progenitor cells 
with growth factors and biomaterial substrates to form a three-dimensional (3D) structure that 
supports new bone formation [3–5]. An assortment of materials such as calcium carbonate, 
hydroxyapatite (HAp), bioactive glasses (BG) like 45S5 BG, tricalcium phosphate (TCP), 
biphasic ceramics of HAp and α- or β-TCP, biopolymers and numerous biodegradable 
polymer–ceramic composites are of great interest for the development of bone substitutes in 
bone repairing and reconstruction [2,6,7]. Nevertheless, bone regeneration is a complex 
process that involves the coordination of a variety of different cascades and can be typically 
characterized by initial inflammatory response, followed by bone formation, vascularization 
and bone remodeling [8]. From the beginning, osteoclasts are fundamentally engaged in the 
whole interactive process, but, interestingly, there is a lack of research of osteoclast 
interaction with bone substitutes. Important parameters determining osteoclast differentiation 
and bone resorption activity with biomaterial bone substrates are material composition, 
roughness, crystal grain size and surface energy and wettability, as reviewed elsewhere [2]. 
A few in vitro cell culture studies using a variety of cell types e.g. U-937 and RAW 264.7 
monocytic-macrophage leukemia cells, fibroblasts, endothelial cells and primary osteoclast 
progenitors have been carried out with several of the above bone substitute materials to not 
only assess osteoclast differentiation and osteoclast activity but also secretion of cellular 
factors [2]. Specifically, the RAW 264.7 murine leukemia cell line has been used as an 
important in vitro cell culture model for studying activation and differentiation into osteoclast-
like cells [9,10]. For example, when RAW 264.7 cells were grown for 14 days on HAp and 
stimulated with RANKL, differentiation via cell fusion occurred into osteoclast-like 
multinucleated cells [9]. Additionally, 3D cell culture scaffolds composed of biphasic calcium 
phosphate (BCP) biomaterial, human plasma clots, and RAW 264.7 cells stimulated for 2 
days in the presence of a transfected overexpression vector containing a glutathione-S 
transferase (GST)-RANKL fusion protein demonstrated significantly increased expression of 
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Vegfa and Vegfc compared to untreated controls [11]. When RAW 264.7 cells were cultured 
in the presence of 3D printed scaffold surfaces, composed of pure HA and β-TCP or a 
biphasic mixture of HA and TCP (60:40), cellular proliferation and differentiation into TRAP 
5b positive stained osteoclast-like cells with resorbing activity occurred [12]. Importantly, an 
increase of osteoclastic specific genes with expression of various markers (e.g. integrin β3, 
integrin αv, CA isoform II, RANK, cathepsin K) was also found, thus supporting ceramic 
substances as effective bone substitutes. 
Despite the complexities of osteoclast biology, the cellular process of bone resorption 
has been successfully mimicked in vitro using different bone substitutes in tissue-engineering 
approaches in order to understand how osteoclast development occurs and the influences 
that different substrates have on this process [13–16]. There is a need for better clinical 
options for the patient regarding bio-engineered bone substitutes, which not only support 
bone regeneration but, at the same time degrade at a suitable rate. One important 
biomaterial being considered in bone regeneration approaches is bioactive glass [17], in 
particular 45S5 BG of the composition (wt%) 45% SiO2, 24.5% Na2O, 24.5% CaO, and 6% 
P2O5, including its variant in nanoparticle morphology [18]. Presently, to our knowledge, there 
are no studies regarding the differentiation and behavior of osteoclasts in the presence of 
nanoscaled (n) 45S5 bioactive glass (BG), despite the fact that this material has shown 
enhanced bioactivity in vitro [19] and has been available for the last 10 years [20]. In a 
continuing search for compatible bone substitutes this investigation examined for the first 
time 45S5 nBG and its influence on osteoclast differentiation, osteoclast activity, cytokine 
and growth factor production using the RAW 264.7 murine monocytic-macrophage leukemia 
cell line.  
2. Materials and Methods 
2.1 Bioactive glass 
Nanoscaled bioactive glass (nBG) particles of nominal composition (in wt%): 47.8% SiO2, 
25.1% CaO, 22.6% Na2O and 4.6% P2O5, were synthesized by means of flame spray 
synthesis, as described elsewhere [20]. Using high temperature synthesis results in a 
relatively homogenous amorphous material with controllable particle size and surface area. 
Briefly, synthesis was performed by combining and mixing the corresponding liquid metal 
precursors with anion precursors and then feeding the mixture into a flame reactor. The 
resulting nanopowder was collected on a filter mounted above the flame. The specific 
surface area of the obtained nBG was 60 - 80 m2 g-1, while the particle size ranges between 
20 - 60 nm. Sterilization was performed by dry heat at 160 °C during 7 h in a furnace (B180, 
Nabertherm, Germany). For cell culture experiments the 45S5 nBG was added directly into 
the cell growth medium.   
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2.2 Cell culture 
For cell culture experiments we used the RAW 264.7 cell line, a mouse leukaemic 
monocyte–macrophage cell line established from an ascites derived from intraperitoneal 
injection of the Abselon murine leukaemia virus (AMuLV) into a male mouse. In 48-well 
plates 1x105 RAW 264.7 cells were cultured in alpha-Minimal Essential Medium (Gibco, 
Germany) containing fetal calf serum (10%) in a final volume of 600 µl for 14 days. 
Additionally, the used differentiation media (DM) were supplemented with macrophage 
colony-stimulating factor (murine M-CSF, 25 ng. ml-1, Biochrom, Germany) and the receptor 
activator of the NF kappa-B ligand (murine RANKL, 40 ng ml-1, Biochrom, Germany).  
2.3 Cell proliferation and viability  
After an incubation period of 14 days, RAW 267.4 cells were analyzed for cell proliferation by 
quantifying the amount of DNA synthesis and cell viability by assessing mitochondrial 
activity. The 5-bromo-2'-deoxyuridine (BrdU) assay (Roche, Germany) is based on the 
detection of BrdU incorporation into genomic DNA of proliferating cells. Following 
incorporation, BrdU was then colorimetrically detected by an ELISA reader (Phomo, Anthos 
Mikrosysteme GmbH, Germany). The mitochondrial activity of cytokine stimulated RAW 
267.4 cells was measured for absorbance at 450 nm in a 96 well plate following the 
conversion of tetrazolium (WST-1, Roche, Germany) to formazan by endogenous 
mitochondrial enzymes. In parallel, using phase contrast microscopy (Axiovert, Zeiss, 
Germany) an analysis was performed to address the overall cellular phenotype.  
2.4 RNA extraction and cDNA synthesis  
Total RNA was extracted from cells according to previously published methods [21]. After 
RNA was pre-treated with DNaseI (Roche, Germany) cDNA was generated with the High 
Capacity cDNA kit (Applied Biosystems, Germany) at 37°C in a thermal cycler for 2h. Semi-
quantitative real time PCR (sqPCR) with SYBR-green was performed with specific primers 
for Ctsk, Trap5, Car2, Vegfa, Rank-l, Ror-2, Syncytin-A and Syncytin-B (Supple.Tab.1). Co-
amplification of 18SrRNA and one control cDNA was used as internal control and for the 2-
ΔΔ
CT calculation.  
2.5 Imaging  
TRAP5 staining: Cell morphology and TRAP5-staining were imaged using bright field 
microscopy (Axiovert, Zeiss, Germany). The formation of tartrate resistant acid phosphatase 
(TRAP5)-positive cells was determined by using a commercially available kit (Sigma, 
Germany). Cells were fixed and stained after 14 days of cultivation, then examined using 
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light microscopy (Axiovert, Zeiss, Germany), where TRAP-positive cells were a maroon 
color.  
Cellular cytoskeleton and nBG mineral detection: To observe the formation of the 
cytoskeleton ‘actin ring’, the cell distribution and the mineralization process occurring with the 
45S5 nBG particles we used fluorescence microscopy (FM, Scope.A1, Carl Zeiss, Germany) 
and confocal scanning laser microscopy (CSLM, Leica TCS SP5 II, Germany). After 14 days 
of cultivation, adherent cells were fixed with 3.7% paraformaldehyde for 10min and then 
permeabilized with 0.1 vol.% Triton X-100 (in PBS) for 10min RT. The fluorescent red-range 
Alexa Fluor® Phalloidin actin binding compound (Molecular Probes®, Germany) (679 nm 
excitation and 702 nm emission) was used to detect the cytoskeleton. The fluorescent blue-
range DNA binding compound, DAPI (4’,6-diamidino-2-phenylindoledihydrochloride; 350 nm 
excitation and 465 nm emission) (Roche) was used for detection of nuclei. Briefly, cells were 
incubated for 60 minutes with phalloidin (diluted 1:50 by volume) at room temperature 
followed by an incubation with 1 µg/ml DAPI for 5min. Mineralization of the 45S5 nBG in all 
cell culture samples was visualized by sample staining using the OsteoImage™ 
Mineralization Assay (Lonza, Germany), where the stock solution was diluted 1:100 (v/v) and 
then subsequently incubated for 30 minutes at room temperature. Samples were washed 
and stored in 1x PBS until microscopic imaging. 3D confocal microscopic images were 
obtained and computer processed (Amira 3D Software for Life Sciences, FEI, USA) to build 
3D schematic images.  
2.6 Scanning electron microscopy: After 14 days the interaction of nBG with the cell 
membrane of cultured RAW cells was characterized using scanning electron microscopy 
(SEM): (Auriga CrossBeam, Carl Zeiss Microscopy GmbH, Germany). Briefly, cells were 
detached by a cell scraper and the remaining samples were directly collected and 
centrifuged using 200 g. Afterwards, the supernatant was removed and the cell pellet was 
fixed in 3 vol.% paraformaldehyde, 3 vol.% glutaraldehyde (Sigma-Aldrich, Germany) and 0.2 
M sodiumcacodylate (Sigma-Aldrich, Germany). After dehydration through incubation with a 
series of graded ethanol series (30, 50, 70, 80, 90, 95 and 100 vol.%), the samples were 
critical point dried with CO2 (EM CPD300, Leica, Germany) and imaged without sputtering.  
2.7 Statistics:  
Data are presented as means ± SEM. All results were analyzed using the non-parametric 
Mann-Whitney-U test for independent samples. Statistical significance was set at P < 0.05 = 
* and P<0.005 = **. All statistical tests were processed using SPSS 21 (IBM, New York, 
USA).  
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3. Results  
3.1 45S5 nBG promotes rapid cell interaction and adherence of RAW 264.7 cells. 
In order to determine the influence of 45S5 nBG on cellular morphology we cultured RAW 
264.7 cells for 14 days in DM with a range of 45S5 nBG concentrations (0.1 µg/ml - 1000 
µg/ml) (Fig.1A). Following cell seeding, lower 45S5 nBG concentrations (0.1 - 100 µg/ml) 
revealed that RAW 264.7 cells were morphologically similar to cells seeded on the reference, 
where they were rounded in appearance with only a few cells attached (Fig. 1A). In contrast, 
for cells seeded in the presence of 500 µg/ml or 1000 µg/ml 45S5 nBG, we observed larger 
cell clusters which appeared well attached to the surface, supporting that 45S5 nBG at a 
higher concentration facilitates a rapid recovery time for cellular interaction and attachment 
(Fig.1A and data not shown). After 14 days of growth, the cells demonstrated many round 
cellular clusters and the presence of multinucleated cells for all 45S5 nBG concentrations 
(0.1 µg/ml - 500 µg/ml).  
3.2 45S5 nBG promotes high viability and proliferation of RAW 264.7 cells.  
Addressing both the cellular proliferation and viability after 14 days of growth we observed 
that RAW 264.7 cells showed high proliferation (~10-15% above the reference; 120%) with a 
viability of ~80% between 0.1 µg/ml - 100 µg/ml 45S5 nBG (Fig. 1B). Although cell viability 
was high when RAW 264.7 cells were grown in the presence of 500 µg/ml nBG, the cell 
proliferation halted, supporting a shift in phenotype of monocyte-macrophage cells to 
terminally differentiated osteoclasts (Fig. 1B). Importantly, at nBG concentrations of 1000 
µg/ml cell viability and proliferation significantly dropped below 10% along with an increase of 
pH to 9.8, thus this concentration resulted in cellular toxicity after 14 days of cultivation. As 
can be seen in the LM-images (Suppl. Fig. 1), 1000 µg/ml of nBG on stimulated RAW cells 
showed no cytotoxic effect after 6 days of incubation, but afterwards more and more cells 
showed necrotic injuries. We further determined that the LC50 value for 45S5 nBG was 
approximately 790 µg/ml (data not shown). For additional experiments described below, 
although we examined all 45S5 nBG concentrations, we mainly focused on the influence of 
the 500 µg/ml concentration correlating with the terminally differentiated state of osteoclasts. 
3.3 Gene expression of specific genes is linked with osteoclast differentiation and 
vascularization.  
Because expression of marker genes correlates with osteoclast differentiation, we examined 
the expression of Cd14, Rankl, Trap5a/b, Ca2, Cathepsin k (Ctsk), Vegfa and Ror2 in RAW 
264.7 cells with increasing concentrations of nBG in DM. Importantly, the mouse 
endogenous retroviral (ERV) envelope genes Syncytin-A and Syncytin-B, functional 
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orthologues to the human cell fusogenic envelope genes, ERVW-1 and ERVFRD-1 called 
Syncytin-1 and Syncytin-2 were also analyzed. Syncytin-A and Syncytin-B were identified at 
the mouse placental syncytiotrophoblast layer, which is formed early in development 
following multiple cell fusions of trophoblast progenitor cells [22].  
Results showed that when cells were grown in DM, five genes, namely Ctsk, Ca2, Vegf-a, 
Trap5a/b and Cd14 were significantly increased in expression at 500 µg/ml 45S5 nBG (Fig. 
2). These results demonstrated that RAW 264.7 cells clearly express genes associated with 
osteoclast differentiation but also still express the monocyte surface marker Cd14. 
Interestingly, at lower concentrations of nBG (between 0.05 - 5.0 µg/ml) a significant 
expression of Rankl was observed, thus these cells most likely secrete this protein 
contributing to autocrine regulation and differentiation. Additionally, Ror2, Syncytin-A and 
Syncytin-B demonstrated significant increases of expression at lower 45S5 nBG 
concentrations (0.5 - 5.0 µg/ml), supporting that commitment and initiation of cell fusion occur 
early.  
3.4 45S5 nBG promotes differentiation of RAW 264.7 TRAP positive expressing osteoclast-
like cells. 
To test the influence of 45S5 nBG concentrations on osteoclast differentiation of RAW 264.7 
cells we assayed for TRAP positive cells after 14 days of growth. Although the mean cellular 
size remained constant (~ 20 µm) when cells were cultured with increasing concentrations of 
45S5 nBG in culture media without growth factors, an increase in the number of TRAP 
positive single cells was observed above 100 µg/ml 45S5 nBG (data not shown). This finding 
supports that in the presence of higher concentrations of 45S5 nBG, RAW 264.7 cells 
become stimulated to produce TRAP but without formation of multi-nucleated osteoclast 
cells. On the other hand, when cells were grown for 14 days with M-CSF and RANKL we 
observed TRAP induction in both single and multinucleated cells with a mean cell size which 
increased from ~40 µm to 55 µm (mean = 38 µm) in agreement with low to high 45S5 nBG 
concentrations (Fig. 3).  
3.5 Detection of multi-nucleated RAW 264.7 cells and mineral complexes of calcium 
phosphate / 45S5 nBG using fluorescence microscopy. 
To further confirm the presence of multi-nucleated cells we analyzed RAW 264.7 cells 
cultured with different concentrations of 45S5 nBG using fluorescence microscopy. Results 
not only confirmed the presence of multi-nucleated osteoclast cells but also formation of the 
classic ‘actin ring’ (Fig. 4). For example, we observed an increase of mean cell size (55 µm) 
and the presence of multi-nucleated cells with a prominent ‘actin ring’ when RAW 264.7 cells 
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were cultured with 500 µg/ml 45S5 nBG (Fig. 4A). In parallel, we localized Ca2+and PO43- 
ions associated with nBG in cell cultures after 14 days of growth and with increasing nBG 
concentrations (Fig. 4A). Using fluorescence microscopy we found calcium phosphate 
particles specifically associated with phalloidin stained cells throughout the cell culture. 
During the cultivation period of 14 days nBG sedimented on the bottom of the cell culture 
dish next to the adherent grown osteoclast-like cells. To examine these clusters in more 
detail confocal microscopy (Fig 4B-C) showed that clusters of calcium phosphate and nBG 
were associated together and with the cell membrane (below and on top). Therefore, our 
results demonstrate that RAW 264.7 cells associate specifically with calcium phosphate  / 
nBG complexes.  
3.6 Detection of cell surface nBG/mineral complexes using scanning electron microscopy 
(SEM). 
To further confirm the association of nBG/mineral complexes with RAW 264.7 cells we 
performed SEM analyses at day 14 of cell growth in DM (Fig 5 A,B). Imaging results showed, 
following centrifugation of cells, no detection of mineral complexes associated with nBG, 
whilst cells were found in the overview (Fig.5 A). In contrast, imaging cells at higher 
magnification showed prominent mineral complexes associated with nBG and cells. 
4. Discussion 
The process of bone homeostasis and bone remodeling occurs throughout the life of 
higher vertebrates and in mammals. In order to maintain a critical skeletal mass there is a 
delicate balance between bone resorption and synthesis [23,24]. This is achieved by 
specialized terminally differentiated hematopoetic cells, namely osteoclasts and osteoblasts, 
respectively, where cross talk via growth factors and cytokines (e.g. interleukins-1and -6) is 
prominent between both cell types [2]. In particular, following cytokine secretion from 
osteoblast lineage cells [e.g. macrophage colony stimulating factor (M-CSF), receptor 
activator of the NF-κB ligand (RANK-L)], stimulation of bone marrow monocytic progenitors 
differentiate into osteoclasts with bone-resorbing activities [2]. Whereas RANKL stimulates 
several aspects of osteoclast function, OPG (osteoprotegerin) blocks RANKL, and inhibits 
bone resorption [25]. In in vitro studies, differentiation of different cell types into functioning 
osteoclast-like cells has been reported to occur upon cytokine stimulation [26–28]. Bioactive 
glasses are important biomaterials for bone tissue regeneration due to their bioactivity and 
osteoconductivity [15, 16, 27]. Since the discovery of 45S5 BG in 1971 there have been over 
one million patients who have received this bone substitute for surgery [15, 28]. More 
recently, the advantages of 45S5 BG for use as scaffold materials for tissue engineering 
have been investigated including biodegradation, increased apatite formation, promotion of 
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osteo and angiogenic properties and the establishment of chemical bonds with the 
surrounding bone tissue [27, 28, 29]. Nanoparticles or granules for clinical use have the 
advantage that they can be easily pushed and formed into a bone defect. nBG of nominal 
45S5 composition (available since 2006 [18]) has not been extensively tested using in vitro 
cell culture studies. Granules, especially nanoparticles, for clinical use applied in a gel or 
paste can be easily pushed and formed into a bone defect while maintaining its advantage of 
a high reactivity”. The beneficial application of nBG incorporated in a covalently crosslinked 
alginate dialdehyde-gelatin hydrogel matrix is shown already in vitro and in vivo by 
Rottensteiner et al.[31]. Beside pastes and putties use, these hybrid systems are also 
promising approaches for additive manufacturing of biomedical implants and even for 
biofabrication [32,33].  
Our present investigation for the first time brings forth biological and physical 
information regarding the influence that different nBG concentrations have on cell viability, 
proliferation, differentiation and gene expression using RAW 264.7 monocyte-macrophage 
cells, which can be stimulated to differentiate into osteoclast-like cells. Interestingly, when 
human peripheral mononuclear cells (hPBMNC) stimulated with M-CSF and RANKL in the 
contact with different nBG concentrations for 14 days, they indicated higher cell activities, but 
similar cell behavior like the RAW 264.7 cells. This is illustrated in the supplementary data, 
where cell proliferation and vitality, TRAP staining and actin ring formation are shown (Suppl. 
Fig. 2 A-C).  
Previous publications using different silica-based nanoparticles incubated with 
different cell types have demonstrated both positive and negative biological outcomes based 
on their physical properties. For example, one study using 50 nm silica nanoparticles 
containing cobalt and a surface modification with polyethylene glycol demonstrated potent 
inhibitory effects on osteoclasts, but on the other hand a stimulatory effect on osteoblasts in 
vitro, and furthermore increased bone density in vivo in mice [34]. Even the presence of Si in 
culture media with nanosized silica and the RAW 264.7 murine monocytic - macrophage cell 
line was shown to inhibit bone resorption [35]. In another study, using sol-gel methodology, 
100 nm nBG particles (SiO2-CaO-P2O5) of atomic ratios of Si:Ca:O:P (28:24:40:2.6) 
increased calcium deposition over 14 days when cultured with mouse pre-osteoblastic cell 
line MC3T3-E1 [36]. In the same study different concentrations of nBG particles 
demonstrated that 100 µg/ml stimulated proliferation but 500 - 1000 µg/ml concentrations 
reduced viability of primary rat osteoprogenitor cells cultured for 24 hrs. Furthermore, using 
sol-gel methodology sub-micron bioactive glass particles (85% SiO2, 15% CaO) with a mean 
particle size of 250 nm demonstrated significant HAp formation in simulated body fluid (SBF) 
after five days and no cytotoxicity with human mesenchymal stem cells (h-MSC); however 
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after 7 days a reduction in cell viability occurred [37]. A comparative study demonstrated that 
nBG particles of various sizes (40 – 1000 nm) and composition 60% SiO2, 36% CaO, and 4% 
P2O5 supported cell adherence and growth with all particle dimensions [38]. These studies 
point to the importance of the chemical composition of bioactive glasses, but also to the 
relevance of nanoparticle size in affecting the regulation of bone cells.  
We previously performed a methodical approach to investigate the structure and 
bioreactivity kinetics of 45S5 nBG in SBF [19]. Additionally we tested the effect of nBG on 
cytotoxicity using the human osteocarcinoma cell line (MG-63), which exhibits osteoblast-like 
behavior [19]. Not only did nBG promote fast formation of HAp along with CaCO3 crystal 
growth within 1 day, but we hypothesized that the increased reactivity was due to the non-
uniform structure and relatively higher surface area of nBG as shown by transmission 
electron microscopy, X-ray diffraction and Fourier transform infrared (FT-IR) spectroscopy 
[19]. Importantly, exposing MG-63 cells to 0.1 – 200 µg/ml nBG increased the proliferative 
growth even at the highest concentration of 1000 µg/ml after 48 hr [19]. In this present 
investigation we used the same 45S5 nBG particles as in ref [17], but we tested them for 
osteoclast differentiation. Considering RAW 264.7 monocyte-macrophage cells we also 
found increased viability (~80%) at lower 45S5 nBG concentrations, which increased at 500 
µg/ml (100% viability) following 14 days of growth in the presence of M-CSF and RANKL. 
One indicator for a terminally differentiated cell is reduced DNA synthesis, thus our findings 
of high viability along with significantly reduced DNA synthesis at 500 µg/ml 45S5 nBG 
supports that at this concentration osteoclasts are fully differentiated. Interestingly, in a co-
culture system of human osteogenic sarcoma cells (SaOs-2) and mouse monocytes (RAW 
264.7) it was shown that 10 mM silicate enhances the growth of osteoblasts, while the 
osteoclastic differentiation of RAW 264.7 cells was strongly decreased [39]. However, as 
Schröder et al. stated in this study, the inhibition of RAW 264.7 cell differentiation cells might 
due to increased levels of OPG, which were synthesized by human osteogenic sarcoma cells 
(SaOS-2) after exposure to silicate. Similar results were shown by Jiao et al. [36], who 
presented an up-regulated OPG expression and a down-regulated RANKL expression in 
mesenchymal stem cells cultured on collagen scaffolds containing silica and apatite, 
resulting in inhibition of the differentiation of RAW 264.7 cells. Summarizing these studies, it 
seems that regarding bone remodeling, silica based materials in a concentration dependent 
manner can inhibit the osteoclast activity indirectly by the stimulation of OPG expression in 
osteoblasts. Support for differentiation of osteoclasts stems from our findings of higher 
numbers of TRAP5 stained positive cells along with increased amounts of multinucleated 
cells with a mean diameter of 55 µm and prominent ‘actin rings’. It is interesting to note that 
when cells were grown in the absence of cytokines we observed an increase of TRAP5 
positive stained cells, but with no significant osteoclast differentiation. This finding indicated 
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that the 45S5 nBG particles alone can activate induction of TRAP gene expression, however 
cytokines are needed to induce pre-osteoclast differentiation into multinucleated cells. This 
finding is corroborated by our results of TRAP5 gene expression levels steadily increasing in 
the presence of 10 µg/ml up to 500 µg/ml nBG with or without M-CSF and RANKL. It has 
also been reported in the literature that bio-polyphosphate induced gene expression of the 
BMP gene in the human osteogenic sarcoma (SaOS-2) cell line [40]. Furthermore, induction 
of genes involved in transcriptional regulation, signal transduction, growth factors and 
cytokines were observed in primary human osteoblasts exposed to ionic dissolution products 
of BG [41,42].  
There are many critical genes and protein signalling promoting osteoclastogenesis in 
a step wise manner; 1) PU.1 transcription factor which initiates commitment of progenitor 
cells; 2) pre-osteoclast differentiation via Wnt5a / Ror2, activation of RANKL signaling with 
transcription factors NFκB, AP-1 and increased levels of nuclear factor of activated T cell 
cytoplasmic 1 (NFATc1); 3) commencement of osteoclast bone resorption; TRAP5, 
cathepsin K, carbonic anhydrase II and VEGF (also essential for angiogenesis) [43–48]. Our 
present gene expression analysis not only demonstrates RAW 264.7 monocyte-macrophage 
cell gene expression of many of these critical genes above, but interestingly, supports the 
idea that osteoclast genes are regulated by different concentrations of 45S5 nBG. For 
example, both Ror-2 and Rankl gene expression levels induced with a 5-fold induction at 10 
µg/ml, but then steadily decreased at higher nBG concentrations, supporting autocrine 
regulation and osteoclast commitment of RAW 264.7 cells. In line with commitment, the 
mouse developmental genes Syncytin-A and Syncytin-B, essential for cell fusion of 
trophoblast progenitors to the multinucleated syncytiotrophoblast [22], were significantly 
induced in expression around the same nBG concentration as Rankl. Interestingly, human 
Syncytin-1 was previously shown to mediate cell fusions of pre-osteoclasts to osteoclasts by 
RNA, protein expression studies and in vitro using a Syncytin-1 peptide which inhibited 
osteoclast differentiation [49]. Therefore, it is conceivable that Syncytin-A and Syncytin-B 
could play a role in cell fusion during osteoclast differentiation in the mouse. Lastly, at 
concentrations above 100 µg/ml at  500 µg/ml differentiating osteoclasts showed a steep 
increase of gene expression of Ctsk, Car-2, Trap5 and Vegfa, supporting that terminally 
differentiated osteoclasts have bone resorbing activity, but additionally could be a trigger for 
angiogenesis. It is interesting to note that in another study secretion of VEGF by human 
fibroblast cells appeared to be dependent on particle size and concentration of a different 
bioactive glass (BG S53P4) [50]. Indeed the angiogenic effect 45S5 BG has been reported 
by several authors, as reviewed by	   Gorustovich et al [30]. Furthermore, our results 
demonstrating that clusters of calcium phosphate with nBG specifically associated with the 
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cellular membrane supports that the presence of intercellular nBG could be a factor leading 
to gene activation and subsequent osteoclast differentiation. 
5. Conclusions 
We conclude that 45S5 nBG promotes: 
1) Rapid RAW 264.7 cell interaction, attachment, high viability and proliferation. 
2) Differentiation of TRAP5 positive expressing osteoclast-like cells.  
3) Differentiation into osteoclast-like multinucleated cells. 
4) Regulation of osteoclast genes, which is dependent on nBG concentration. 
5) Mineralization and direct association of nBG with cells. 
Taken together, we further conclude that nBG enhances RAW 264.7 osteoclast 
differentiation especially by controlling gene expression in a concentration dependent 
manner, which could reflect normal regulation during bone growth and remodeling. 
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Figure 1 Cell morphology, proliferation and viability of RAW 264.7 cells after seeding 
and 14 days of culturing in DM with increasing concentrations of nBG. A. Concentration 
of nBG (0µg/ml-1000µg/ml correlates with a light microscopic morphological analyses of 
RAW cells at day 0 (left column, scale bare = 100 µm) and after day 14 (right column, (scale 
bare = 50 µm) of cultures with DM. Note that we observed cytotoxicity and increased pH 
levels (pH 9.8) at 1000µg/ml with an LC50 value of approximately 790 µg/ml. DM = 
differentiation media containing M-CSF and Rankl. B. Graph shows cell proliferation (%) 
using BrdU Synthesis (black columns) and viability determined using mitochrondrial activity 
(%) (grey striped columns) on y-axis of RAW 264.7 cells after 14 days with DM with 
increasing concentrations of nBG indicated on the x-axis. Statistically significant levels are 
indicated with * p<0.05 and ** p<0.001. 
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Figure 2. Gene expression analyses of RAW 264.7 cells after 14 days of culturing in 
DM with increasing concentrations of nBG. RNA was analyzed at day 14 from RAW 264.7 
cells grown in DM with increasing concentrations of nBG. Gene expression was analysed for 
nine different genes involved in cellular fusion, osteoclast commitment and differentiation. 
Graphs show gene name indicated above; Y-axis represents gene expression in fold 
increase over control (without nBG) set to 1; x-axis represents bar graphs of mean gene 
expression levels from 4 independent experiments (sem indicated) at each concentration of 
nBG (µg/ml). Statistically significant gene expression levels are indicated with * p<0.05 and 
** p<0.001. Table below shows gene name with fold increase gene expression values with 
control set to 1, sem values and p-values. DM = differentiation media containing M-CSF and 
Rankl.  
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Figure 3. Analyses of Trap5 protein expression of RAW 264.7 cells after 14 days of 
culturing in DM with increasing concentrations of nBG. Top and bottom row of 
microscopic pictures showing Trap5 cellular staining correlates with increasing 
concentrations of nBG 0µg/ml-1000µg/ml. Arrows show Trap5 positive multinucleated cells 
(scale bare = 50 µm). 
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Figure 4. Analyses of actin intermediate filaments of RAW 264.7 cells and increased 
mineralization after 14 days of culturing in DM with increasing concentrations of nBG. 
A. Top and bottom row of fluorescent microscopic pictures (scale bare = 200 µm) show RAW 
264.7 cells staining positive for actin filaments (red phalloidin dye) and nuclear detection 
(DAPI) and detection of mineral complexes throughout the cell culture. Pictures correlate with 
increasing concentrations of nBG (0µg/ml-500µg/ml). Examples show positive multinucleated 
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cells with the classic actin ring and mineral complexes (green). Inset pictures represent 
magnified regions. B. Confocal microscopy showing actin ring and mineral complexes of 
RAW 264.7 cells and increased mineralization after 14 days of culturing in DM at 500µg/ml of 
nBG (scale bare = 25 µm). A single representative confocal scan is shown demonstrating the 
actin rings (phalloidin dye, B left), mineral complexes (green, B center) and merged (B right). 
C. 3D picture (Amira) based upon a confocal stack of images with a step size of 1.01 µm and 
a distance of 76.54 µm. Note the association of mineral complexes with the cell membrane 
and also encapsulated within the cell cytoplasm.   
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Figure 5. SEM images of RAW 264.7 cells and increased mineralization after 14 days of 
culturing in DM at 500µg/ml of nBG. Top picture shows the cell pellet using SEM at day 14 
and the bottom picture shows SEM analyses of the cell surfaces (grey) and associated 
mineral complexes (light grey/white). 
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Supplementary data 1 
Table 1: Primers 
Name TF for qPCR (5‘à3‘) BR for qPCR (5‘à3‘) 
18srRNA ATGGCCCTTAGTTGGTG GAACGCCACTTGTCCCTCTA 
Syncytin-A*  GATGACATCCACTGCCACAC ATTGTCCGGCTCGAATAGG 
Syncytin-B*  TTACCATGTCAGTGAACCCTACC CGTTCTCCCAGACTGAATATTGT 
mCD14 CAAGGTACTGAGTATTGCCCAAG TCAGACAGGTCTAAGGTGGAGAG 
mRankl TCCCATAAAGTCACTCTGTCCTC AAGCCATCTTGGTTAACCCTTAG 
mCathepsin-K AATCTTGTGGACTGTGTGACTGA ATGGGTAAGCATCTTCAGAGTCA 
mTrap5 GTCTCTGCACAGATTGCATACTCTA CCACAGTTATGTTTGTACGTGGA 
mRor-2 ATGATTGAATGCTGGAATGAGTT AGGTCTGCGCGGAACTATTAT 
mCar2 GAAGCACTGCATTCCATTAAAAC CAGGGTATGTCCAGTAGTCCAAG 
mVegfa AGAAAGCATTTGTTTGTCCAAGAT ATCTGCAAGTACGTTCGTTTAACTC 
Trap5= tartrate resistant acid phosphatase 5  
Ror-2 = receptor tyrosine kinase-like orphan receptor 2 
Car2= carbonic anhydrase 2 
Vegfa= vascular endothelial growth factor A 
 
* Syncytin-A, Syncytin-B and 18srRNA primer according to Henke et al. 2013. 
Supplementary data 2 
Light microscopic images of RAW 264.7 cells incubated with 1000 µg/ml nBG were used to 
analyse the cytotoxic effect of high nBG concentration on monocytes.  
 
Supplement-Fig. 1: LM-images of stimulated RAW cells in contact with 1000 µg/ml after 
seeding, after 6d, 10d, 12 and 14 days. (images from day 0 and 14 taken from Fig. 1A) 
 
Supplementary data 3: human PBMNC incubated with nBG for 14d  
For additional experiments human peripheral mononuclear cells (hPBMNC) were isolated by 
Ficoll-Paque sedimentation from volunteers (ethical permission from the University-Clinic 
Erlangen: 139 14B, 06.05.2014) and incubated in alpha-minimal essential medium with 10 
vol.% fetal calf serum and with a range of 45S5 nBG concentrations (0.1 µg/ml - 1000 µg/ml) 
for 14 days, stimulated with macrophage colony-stimulating factor (human M-CSF, 25 ng/ml) 
and receptor activator of the NFkappaB ligand (human RANKL, 40 ng/ml). The measurement 
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(following chapter 2.3) of proliferation and viability after 14 days of growth hPBMNC showed 
higher proliferation compared to the reference (100 µg/ml) and high stimulation effects on cell 
viability (Supplement-Fig. 1A). Again importantly, at nBG concentrations of 500 µg/ml cell 
proliferation significantly dropped below 40%. TRAP-staining (following chapter 2.5) was 
used to identify the osteoclastic differentiation. Therefore, hPBMNC were analysed for 14 
days in DM with a range of 45S5 nBG concentrations (0.1 µg/ml - 500 µg/ml): TRAP positive 
cells were found on all samples (Supplement-Fig. 1B). Furthermore, fluorescent microscopic 
images (Supplement-Fig. 1C) show hPBMC staining positive for actin filaments (red 
phalloidin dye) and nuclear detection (green, Sytox). Examples show positive multinucleated 
cells (in max. 9 nuclei) with the classic actin ring formation. 
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Supplement-Fig. 2 A: Cell proliferation and viability of hPBMNC after 14 days of culturing 
with increasing concentrations of nBG. Statistically significant levels are indicated with * 
p<0.05 and ** p<0.001.B: Analyses of Trap5 protein expression hPBMNC cells after 14 days 
of culturing with increasing concentrations of nBG (scale bare = 100 µm). C: Analyses of 
actin intermediate filaments of hPBMNC after 14 days of culturing with increasing 
concentrations of nBG (scale bare = 100 µm).  
